Drugs / (PN-152,243)/PN-196,444
last change Sep 2002 re-read 3 minutes ago

(PN-152,243)/PN-196,444

Developed for
thrombocytopenia
Investigated by
Pfizer

Trials 1

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00037791 Dec 1999 → Sep 2002 plasma cell myeloma, thrombocytopenia Pfizer Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as (PN-152,243)/PN-196,444 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00037791 ↗